Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer.
Saved in:
| Title: | Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer. |
|---|---|
| Authors: | Makovec A; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Boytim E; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Gustafson A; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Ludwig M; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Department of Pharmacology, University of Minnesota- Twin Cities, Minneapolis, MN, USA., Wang L; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Department of Pediatrics, Medical School, University of Minnesota- Twin Cities, Minneapolis, MN, USA., Ali A; Bioinformatic Interdepartmental Program, University of California, Los Angeles, CA, USA., Ishani K; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Luo C; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Bergom HE; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., John E; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Tape S; Medical College of Wisconsin, Green Bay, WI, USA., Kellen S; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Deacon A; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Dewji FI; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Richter C; Rush University Medical College, Chicago, IL, USA., Cookle L; University of Minnesota- Twin Cities, Minneapolis, MN, USA., Moline D; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Rennhack JP; Department of Cancer Biology, Loyola University Chicago, Chicago, IL, USA., Drake JM; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Department of Pharmacology, University of Minnesota- Twin Cities, Minneapolis, MN, USA., Antonarakis ES; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Largaespada DA; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Department of Pediatrics, Medical School, University of Minnesota- Twin Cities, Minneapolis, MN, USA., Ostrander JH; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Hwang J; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA. jhwang@umn.edu.; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA. jhwang@umn.edu. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2025 Nov 20; Vol. 9 (1), pp. 367. Date of Electronic Publication: 2025 Nov 20. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-025-01168-1 |
